NYSE:STE

STERIS Stock Forecast, Price & News

$189.53

+0.82 (+0.43 %)

(As of 01/20/2021 12:00 AM ET)

Add

Compare

Today's Range

$188.25

Now: $189.53▼

$191.30

50-Day Range

$181.76

MA: $189.43▼

$202.81

52-Week Range

$105.69

Now: $189.53▼

$203.90

Volume401,525 shs

Average Volume499,791 shs

Market Capitalization$16.17 billion

P/E Ratio38.44

Dividend Yield0.85%

Beta0.59

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services. This segment offers its products and services to acute care hospitals, ambulatory surgery centers, and GI clinics. The Healthcare Specialty Services segment provides solutions and managed services, such as instrument and endoscope repair and maintenance solutions; custom process improvement consulting services; and outsourced instrument sterile processing services to acute care hospitals and other healthcare settings. The Life Sciences segment offers formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The company was founded in 1985 and is based in Dublin, Ireland.

MarketRank^™

Overall MarketRank^™

2.13 out of 5 stars

Medical Sector

34th out of 1,928 stocks

Surgical Appliances & Supplies Industry

1st out of 41 stocks

2.3 Analyst's Opinion

Consensus Rating
STERIS has received a consensus rating of Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $210.00, STERIS has a forecasted upside of 10.8% from its current price of $189.53.
Amount of Analyst Coverage
STERIS has only been the subject of 3 research reports in the past 90 days.

2.1 Community Rank

Outperform Votes
STERIS has received 282 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
STERIS has received 389 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
STERIS has received 57.97% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about STERIS and other stocks. Vote “Outperform” if you believe STE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe STE will underperform the S&P 500 over the long term. You may vote once every thirty days.

3.3 Dividend Strength

Dividend Yield
STERIS has a dividend yield of 0.85%, which is in the bottom 25% of all stocks that pay dividends.
Dividend Growth
STERIS has been increasing its dividend for 14 years.
Dividend Coverage
The dividend payout ratio of STERIS is 28.37%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, STERIS will have a dividend payout ratio of 23.32% next year. This indicates that STERIS will be able to sustain or increase its dividend.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, STERIS insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $3,503,903.00 in company stock.
Percentage Held by Insiders
Only 1.20% of the stock of STERIS is held by insiders.
Percentage Held by Institutions
90.01% of the stock of STERIS is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3 Earnings and Valuation

Earnings Growth
Earnings for STERIS are expected to grow by 13.76% in the coming year, from $6.03 to $6.86 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of STERIS is 38.44, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 23.67.
Price to Earnings Ratio vs. Sector
The P/E ratio of STERIS is 38.44, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 35.92.
Price to Book Value per Share Ratio
STERIS has a P/B Ratio of 4.72. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Surgical appliances & supplies

Sub-IndustryHealth Care Equipment

SectorMedical

Current SymbolNYSE:STE

Previous Symbol

CUSIP85915210

CIK1624899

Webwww.steris.com

Phone353-1232-2000

Employees13,000

Debt

Debt-to-Equity Ratio0.28

Current Ratio2.64

Quick Ratio2.00

Price-To-Earnings

Trailing P/E Ratio38.44

Forward P/E Ratio31.43

P/E GrowthN/A

Sales & Book Value

Annual Sales$3.03 billion

Price / Sales5.34

Cash Flow$7.83 per share

Price / Cash Flow24.21

Book Value$40.17 per share

Price / Book4.72

Profitability

EPS (Most Recent Fiscal Year)$5.64

Net Income$407.61 million

Net Margins13.97%

Return on Equity14.44%

Return on Assets9.32%

Miscellaneous

Outstanding Shares85,324,000

Market Cap$16.17 billion

Next Earnings Date2/2/2021 (Confirmed)

OptionableOptionable

$189.53

+0.82 (+0.43 %)

(As of 01/20/2021 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

STERIS (NYSE:STE) Frequently Asked Questions

How has STERIS's stock price been impacted by COVID-19 (Coronavirus)?

STERIS's stock was trading at $145.25 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, STE shares have increased by 30.5% and is now trading at $189.53.
View which stocks have been most impacted by COVID-19.

Is STERIS a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" STERIS stock.
View analyst ratings for STERIS or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than STERIS?

Wall Street analysts have given STERIS a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but STERIS wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Thomas Greco's approval rating as STERIS's CEO?

538 employees have rated STERIS CEO Thomas Greco on Glassdoor.com. Thomas Greco has an approval rating of 63% among STERIS's employees. This puts Thomas Greco in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

When is STERIS's next earnings date?

STERIS is scheduled to release its next quarterly earnings announcement on Tuesday, February 2nd 2021.
View our earnings forecast for STERIS.

How can I listen to STERIS's earnings call?

STERIS will be holding an earnings conference call on Tuesday, February 2nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were STERIS's earnings last quarter?

STERIS plc (NYSE:STE) announced its quarterly earnings results on Monday, November, 2nd. The medical equipment provider reported $1.48 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.27 by $0.21. The medical equipment provider had revenue of $756.13 million for the quarter, compared to the consensus estimate of $719.54 million. STERIS had a return on equity of 14.44% and a net margin of 13.97%. The business's revenue was up 2.6% on a year-over-year basis. During the same quarter last year, the business earned $1.32 EPS.
View STERIS's earnings history.

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS announced a quarterly dividend on Monday, November 2nd. Investors of record on Tuesday, November 24th will be paid a dividend of $0.40 per share on Friday, December 18th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.84%. The ex-dividend date is Monday, November 23rd.
View STERIS's dividend history.

Is STERIS a good dividend stock?

STERIS pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.85%. STERIS has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of STERIS is 28.37%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, STERIS will have a dividend payout ratio of 23.32% next year. This indicates that STERIS will be able to sustain or increase its dividend.
View STERIS's dividend history.

What price target have analysts set for STE?

5 equities research analysts have issued 12-month price targets for STERIS's shares. Their forecasts range from $200.00 to $230.00. On average, they anticipate STERIS's share price to reach $210.00 in the next twelve months. This suggests a possible upside of 10.8% from the stock's current price.
View analysts' price targets for STERIS or view Wall Street analyst' top-rated stocks.

Who are some of STERIS's key competitors?

Some companies that are related to STERIS include Abbott Laboratories (ABT), Medtronic (MDT), Intuitive Surgical (ISRG), Stryker (SYK), Becton, Dickinson and (BDX), Edwards Lifesciences (EW), Boston Scientific (BSX), IDEXX Laboratories (IDXX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Insulet (PODD), Teleflex (TFX) and Varian Medical Systems (VAR).
View all of STE's competitors.

What other stocks do shareholders of STERIS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), The Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

Who are STERIS's key executives?

STERIS's management team includes the following people:

Mr. Walter M. Rosebrough Jr., CEO, Pres & Director (Age 66, Pay $2.49M)
Mr. Michael J. Tokich, Sr. VP & CFO (Age 51, Pay $1.08M)
Mr. Daniel A. Carestio, Sr. VP & Chief Operating Officer (Age 47, Pay $1.09M)
Mr. John Adam Zangerle, Sr. VP, Gen. Counsel, Sec. (Age 53, Pay $760.33k)
Mr. Cary L. Majors, Sr. VP of North America Commercial Operations (Age 45, Pay $690.69k)
Ms. Karen L. Burton, Chief Accounting Officer, VP & Controller (Age 52)
Julie Winter, Sr. Director of Investor Relations and Corp. Communications
Mr. Sudhir K. Pahwa, Sr. VP of Infection Prevention Technologies (Age 67)
Stephen Norton, Sr. Director of Corp. Communications
Mr. Renato G. Tamaro, VP & Corp. Treasurer (Age 51)

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Who are STERIS's major shareholders?

STERIS's stock is owned by a number of institutional and retail investors. Top institutional investors include Frontier Capital Management Co. LLC (0.47%), Boston Trust Walden Corp (0.21%), Gateway Investment Advisers LLC (0.07%), State of Alaska Department of Revenue (0.04%), Callahan Advisors LLC (0.04%) and Fruth Investment Management (0.02%). Company insiders that own STERIS stock include Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden, Richard Martin Steeves and Walter M Rosebrough Jr.
View institutional ownership trends for STERIS.

Which major investors are selling STERIS stock?

STE stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Denali Advisors LLC, Crossmark Global Holdings Inc., Addenda Capital Inc., Gateway Investment Advisers LLC, and Contravisory Investment Management Inc.. Company insiders that have sold STERIS company stock in the last year include Cary L Majors, Daniel A Carestio, David B Lewis, John Adam Zangerle, Julia Madsen, Karen L Burton, Mohsen Sohi, Richard C Breeden, and Walter M Rosebrough Jr.
View insider buying and selling activity for STERIS or view top insider-selling stocks.

Which major investors are buying STERIS stock?

STE stock was purchased by a variety of institutional investors in the last quarter, including Fruth Investment Management, Pacer Advisors Inc., State of Alaska Department of Revenue, Boston Trust Walden Corp, Kestra Advisory Services LLC, Welch & Forbes LLC, OneAscent Financial Services LLC, and Fulton Bank N.A..
View insider buying and selling activity for STERIS or or view top insider-buying stocks.

How do I buy shares of STERIS?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $189.53.

How big of a company is STERIS?

STERIS has a market capitalization of $16.17 billion and generates $3.03 billion in revenue each year. The medical equipment provider earns $407.61 million in net income (profit) each year or $5.64 on an earnings per share basis. STERIS employs 13,000 workers across the globe.

What is STERIS's official website?

The official website for STERIS is www.steris.com.

How can I contact STERIS?

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The medical equipment provider can be reached via phone at 353-1232-2000 or via email at [email protected]

This page was last updated on 1/21/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here